FDA
-
-
-
-
-
-
-
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
-
-
-
-
-
-
-
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
-
-
-
-
-
-
-
Ligand and Medtronic invest $70 million in Orchestra BioMed
-
-
-
-
-
-
-
Ligand Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
-
-
-
-
-
-
-
Ligand Pharma (LGND) Verona Pharma Announces FDA Approval of Ohtuvayre, First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
-
-
-
-
-
-
-
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
-
334,842 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


